Insurer classified the treatment as experimental. Appeal with FDA approval status, clinical trials, peer-reviewed evidence, and other insurers' coverage.
Insurer classified the treatment as experimental. Appeal with FDA approval status, clinical trials, peer-reviewed evidence, and other insurers' coverage. Recognizing the denial type is the first step — it determines which arguments and evidence will actually move the reviewer.
For Experimental / Investigational denials, the winning approach centers on clinical evidence heavy: directly rebut the insurer's stated reason, then back it with the evidence reviewers respect.
The strongest supporting evidence for this denial type:
CareCost Appeals classifies your denial, pulls the right evidence (real, verified clinical citations and the insurer's own policy where available), applies your state and federal appeal rights, and produces a ready-to-send letter — free.